EdgeRock Capital LLC Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

EdgeRock Capital LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,570 shares of the healthcare conglomerate’s stock after acquiring an additional 82 shares during the quarter. UnitedHealth Group comprises approximately 0.6% of EdgeRock Capital LLC’s portfolio, making the stock its 19th biggest position. EdgeRock Capital LLC’s holdings in UnitedHealth Group were worth $801,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. Hyman Charles D lifted its stake in UnitedHealth Group by 5.5% in the 4th quarter. Hyman Charles D now owns 8,390 shares of the healthcare conglomerate’s stock worth $4,417,000 after purchasing an additional 434 shares in the last quarter. Everpar Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,049,000. Gryphon Financial Partners LLC increased its position in UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock valued at $3,275,000 after purchasing an additional 2,782 shares during the period. Moss Adams Wealth Advisors LLC boosted its position in UnitedHealth Group by 6.0% during the fourth quarter. Moss Adams Wealth Advisors LLC now owns 3,282 shares of the healthcare conglomerate’s stock valued at $1,728,000 after purchasing an additional 185 shares in the last quarter. Finally, Pacific Capital Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $53,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Barclays raised their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a report on Thursday, April 4th. Finally, Truist Financial reissued a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Up 1.3 %

Shares of UNH traded up $6.58 during midday trading on Tuesday, reaching $500.96. The stock had a trading volume of 3,395,758 shares, compared to its average volume of 4,378,167. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company’s fifty day simple moving average is $481.45 and its two-hundred day simple moving average is $511.98. The company has a market cap of $460.92 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 1.43 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the business earned $6.26 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.50%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.